From July 1, 2023 to September 30, 2023, the company has repurchased 3,139,400 shares, representing 0.85% for ¥4,087.94 million. With this, the company has completed the repurchase of 8,809,300 shares, representing 2.36% for ¥11,124.4 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,512 JPY | +1.41% | +4.13% | +7.65% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.65% | 3.5B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.